-
公开(公告)号:US20200276313A1
公开(公告)日:2020-09-03
申请号:US16878385
申请日:2020-05-19
Applicant: AMGEN INC.
Inventor: Christopher James Sloey , Camille Vergara , Jason Ko , Tiansheng Li
IPC: A61K47/24 , A61K9/19 , A61K47/18 , A61K47/22 , A61K39/395
Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from caritine, creatine or creatinine.
-
公开(公告)号:US20130121990A1
公开(公告)日:2013-05-16
申请号:US13742818
申请日:2013-01-16
Applicant: Amgen Inc.
Inventor: Christopher James Sloey , Camille Vergara , Jason Ko , Tiansheng Li
CPC classification number: A61K47/24 , A61K9/0019 , A61K9/19 , A61K39/395 , A61K47/18 , A61K47/183 , A61K47/186 , A61K47/22
Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.
Abstract translation: 提供了稳定的药物制剂,其包含生物活性蛋白质和选自肉碱,肌酸或肌酸酐的赋形剂。
-
公开(公告)号:US09320797B2
公开(公告)日:2016-04-26
申请号:US13742818
申请日:2013-01-16
Applicant: AMGEN INC.
Inventor: Christopher James Sloey , Camille Vergara , Jason Ko , Tiansheng Li
IPC: A61K39/395 , A61K47/22 , A61K9/19 , A61K47/18 , A61K9/00
CPC classification number: A61K47/24 , A61K9/0019 , A61K9/19 , A61K39/395 , A61K47/18 , A61K47/183 , A61K47/186 , A61K47/22
Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.
-
-